Todd Pettingill
Corporate Officer/Principal bei OMNIAB, INC.
Aktive Positionen von Todd Pettingill
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
OMNIAB, INC. | Corporate Officer/Principal | - | - |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | Corporate Officer/Principal | - | - |
Karriereverlauf von Todd Pettingill
Ehemalige bekannte Positionen von Todd Pettingill
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
LIGAND PHARMACEUTICALS INCORPORATED | Investor Relations Kontakt | - | - |
Public Communications Contact | - | - |
Ausbildung von Todd Pettingill
UCLA Anderson School of Management | Masters Business Admin |
Brigham Young University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Corporate Officer/Principal | 2 |
Investor Relations Contact | 1 |
Public Communications Contact | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
OMNIAB, INC. | Commercial Services |
Private Unternehmen | 1 |
---|---|
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | Health Technology |
- Börse
- Insiders
- Todd Pettingill
- Erfahrung